2026-05-22T00:32:28Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/177942024-09-21T18:03:29Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16938col_20.500.12105_16927col_20.500.12105_16958col_20.500.12105_16968col_20.500.12105_16982

00925njm 22002777a 4500 dc González-Flores, E author Serrano, R author Sevilla, I author Viúdez, A author Barriuso, J author Benavent, M author Capdevila, J author Jimenez-Fonseca, P author López, C author Garcia-Carbonero, R author 2018-12-07 NENs are a heterogeneous family of tumors of challenging diagnosis and clinical management. Their incidence and prevalence continue to rise across all sites, stages and grades. Although improved diagnostic techniques have led to earlier detection and stage migration, the improved prognosis documented over time for advanced gastrointestinal and pancreatic neuroendocrine tumors also reflect improvements in therapy. The aim of this guideline is to update practical recommendations for the diagnosis and treatment of gastroenteropancreatic and lung NENs. Diagnostic procedures, histological classification and therapeutic options are briefly discussed, including surgery, liver-directed therapy, peptide receptor radionuclide therapy, and systemic hormonal, cytotoxic or targeted therapy, and treatment algorithms are provided. 10.1007/s12094-018-1980-7 1699-3055 Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico http://hdl.handle.net/10668/13305 30535553 http://hdl.handle.net/20.500.12105/17794 Diagnosis Gastroenteropancreatic Guidelines Lung Neuroendocrine neoplasms Neuroendocrine tumors Therapy SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018).